The Asia Pacific Epigenetics Market would witness market growth of 15.2% CAGR during the forecast period (2022-2028).
DNA methylation, histone methylation, and acetone methylation are some of the most common epigenetic technologies. Strong correlations between DNA methylation and aging have been discovered through research. The International Human Epigenome Consortium, the National Cancer Institute (NCI), and the National Institute of Health (NIH) are all affecting the market in a good way by providing financial support for epigenetics research and development. Moreover, the growing emphasis on studying epigenetic changes at the genetic and molecular level, as well as the development of epigenetics-based medicinal treatments, is likely to have a favorable impact on research funding.
The epigenetics market is primarily driven by technological breakthroughs in the field of epigenetics. In comparison to typical microarrays, epigenetics-based assays are extremely useful and advantageous due to advantages such as the requirement for a low concentration of input material and the lack of experimental bias in microarrays. Advanced epigenetic tools and sequencing platforms have been the subject of research.
Major trends in the APAC region are increased awareness of epigenetics, increased penetration of important players in growing Asia-Pacific countries, and expansion of research and clinical infrastructure. Due to increased disposable income, significant unmet clinical requirements of patients, rising knowledge of early diagnosis, and availability of efficient treatment in emerging nations such as India and China, the market is likely to flourish in the upcoming years. In addition, an increase in instances of various types of malignancies in this region is the prominent growth catalyst for the regional market.
Moreover, the regional market has witnessed increased disposable income, significant unmet clinical needs of patients, growing awareness of early diagnosis, and availability of suitable treatment in emerging nations such as India and China. Because of the increased cases of various forms of malignancies in this region, Asia Pacific is the most promising region for industry players. Market growth is expected to be aided by the growing geriatric population.
The China market dominated the Asia Pacific Epigenetics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $232.4 Million by 2028. The Japan market is anticipated to grow at a CAGR of 14.5% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 15.9% during (2022 - 2028).
Based on Application, the market is segmented into Oncology and Non-Oncology. Based on Product, the market is segmented into Kits, Reagents, Enzymes, and Instruments. Based on End User , the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Contract Research Organizations. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Epigenetics Market is Projected to reach USD 2.9 Billion by 2028, at a CAGR of 14.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abcam plc, Agilent Technologies, Inc., Hologic, Inc., Illumina, Inc., Merck Group, PerkinElmer, Inc., Qiagen N.V., Thermo Fisher Scientific, Inc., Zymo Research, and Active Motif, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Application
By Product
- Kits
- Reagents
- Enzymes
- Instruments
By End User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Abcam plc
- Agilent Technologies, Inc.
- Hologic, Inc.
- Illumina, Inc.
- Merck Group
- PerkinElmer, Inc.
- Qiagen N.V.
- Thermo Fisher Scientific, Inc.
- Zymo Research
- Active Motif, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Epigenetics Market, by Application
1.4.2 Asia Pacific Epigenetics Market, by Product
1.4.3 Asia Pacific Epigenetics Market, by End User
1.4.4 Asia Pacific Epigenetics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2018, Apr – 2021, Dec) Leading Players
Chapter 4. Asia Pacific Epigenetics Market by Application
4.1 Asia Pacific Oncology Market by Country
4.2 Asia Pacific Non Oncology Market by Country
Chapter 5. Asia Pacific Epigenetics Market by Product
5.1 Asia Pacific Kits Market by Country
5.2 Asia Pacific Reagents Market by Country
5.3 Asia Pacific Enzymes Market by Country
5.4 Asia Pacific Instruments Market by Country
Chapter 6. Asia Pacific Epigenetics Market by End User
6.1 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country
6.2 Asia Pacific Academic & Research Institutes Market by Country
6.3 Asia Pacific Contract Research Organizations Market by Country
Chapter 7. Asia Pacific Epigenetics Market by Country
7.1 China Epigenetics Market
7.1.1 China Epigenetics Market by Application
7.1.2 China Epigenetics Market by Product
7.1.3 China Epigenetics Market by End User
7.2 Japan Epigenetics Market
7.2.1 Japan Epigenetics Market by Application
7.2.2 Japan Epigenetics Market by Product
7.2.3 Japan Epigenetics Market by End User
7.3 India Epigenetics Market
7.3.1 India Epigenetics Market by Application
7.3.2 India Epigenetics Market by Product
7.3.3 India Epigenetics Market by End User
7.4 South Korea Epigenetics Market
7.4.1 South Korea Epigenetics Market by Application
7.4.2 South Korea Epigenetics Market by Product
7.4.3 South Korea Epigenetics Market by End User
7.5 Singapore Epigenetics Market
7.5.1 Singapore Epigenetics Market by Application
7.5.2 Singapore Epigenetics Market by Product
7.5.3 Singapore Epigenetics Market by End User
7.6 Malaysia Epigenetics Market
7.6.1 Malaysia Epigenetics Market by Application
7.6.2 Malaysia Epigenetics Market by Product
7.6.3 Malaysia Epigenetics Market by End User
7.7 Rest of Asia Pacific Epigenetics Market
7.7.1 Rest of Asia Pacific Epigenetics Market by Application
7.7.2 Rest of Asia Pacific Epigenetics Market by Product
7.7.3 Rest of Asia Pacific Epigenetics Market by End User
Chapter 8. Company Profiles
8.1 Abcam plc
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.2 Agilent Technologies, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Acquisition and Mergers:
8.3 Hologic, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Illumina, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 Merck Group (Merck Millipore)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.6 PerkinElmer, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.6.5.3 Acquisition and Mergers:
8.7 Qiagen N.V.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Thermo Fisher Scientific, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.9 Zymo Research
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.10. Active Motif, Inc.
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
8.10.2.2 Acquisition and Mergers:
TABLE 1 Asia Pacific Epigenetics Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Epigenetics Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements – Epigenetics Market
TABLE 4 Product Launches And Product Expansions – Epigenetics Market
TABLE 5 Acquisition and Mergers – Epigenetics Market
TABLE 6 Asia Pacific Epigenetics Market by Application, 2018 - 2021, USD Million
TABLE 7 Asia Pacific Epigenetics Market by Application, 2022 - 2028, USD Million
TABLE 8 Asia Pacific Oncology Market by Country, 2018 - 2021, USD Million
TABLE 9 Asia Pacific Oncology Market by Country, 2022 - 2028, USD Million
TABLE 10 Asia Pacific Non Oncology Market by Country, 2018 - 2021, USD Million
TABLE 11 Asia Pacific Non Oncology Market by Country, 2022 - 2028, USD Million
TABLE 12 Asia Pacific Epigenetics Market by Product, 2018 - 2021, USD Million
TABLE 13 Asia Pacific Epigenetics Market by Product, 2022 - 2028, USD Million
TABLE 14 Asia Pacific Kits Market by Country, 2018 - 2021, USD Million
TABLE 15 Asia Pacific Kits Market by Country, 2022 - 2028, USD Million
TABLE 16 Asia Pacific Reagents Market by Country, 2018 - 2021, USD Million
TABLE 17 Asia Pacific Reagents Market by Country, 2022 - 2028, USD Million
TABLE 18 Asia Pacific Enzymes Market by Country, 2018 - 2021, USD Million
TABLE 19 Asia Pacific Enzymes Market by Country, 2022 - 2028, USD Million
TABLE 20 Asia Pacific Instruments Market by Country, 2018 - 2021, USD Million
TABLE 21 Asia Pacific Instruments Market by Country, 2022 - 2028, USD Million
TABLE 22 Asia Pacific Epigenetics Market by End User, 2018 - 2021, USD Million
TABLE 23 Asia Pacific Epigenetics Market by End User, 2022 - 2028, USD Million
TABLE 24 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 25 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 26 Asia Pacific Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 27 Asia Pacific Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 28 Asia Pacific Contract Research Organizations Market by Country, 2018 - 2021, USD Million
TABLE 29 Asia Pacific Contract Research Organizations Market by Country, 2022 - 2028, USD Million
TABLE 30 Asia Pacific Epigenetics Market by Country, 2018 - 2021, USD Million
TABLE 31 Asia Pacific Epigenetics Market by Country, 2022 - 2028, USD Million
TABLE 32 China Epigenetics Market, 2018 - 2021, USD Million
TABLE 33 China Epigenetics Market, 2022 - 2028, USD Million
TABLE 34 China Epigenetics Market by Application, 2018 - 2021, USD Million
TABLE 35 China Epigenetics Market by Application, 2022 - 2028, USD Million
TABLE 36 China Epigenetics Market by Product, 2018 - 2021, USD Million
TABLE 37 China Epigenetics Market by Product, 2022 - 2028, USD Million
TABLE 38 China Epigenetics Market by End User, 2018 - 2021, USD Million
TABLE 39 China Epigenetics Market by End User, 2022 - 2028, USD Million
TABLE 40 Japan Epigenetics Market, 2018 - 2021, USD Million
TABLE 41 Japan Epigenetics Market, 2022 - 2028, USD Million
TABLE 42 Japan Epigenetics Market by Application, 2018 - 2021, USD Million
TABLE 43 Japan Epigenetics Market by Application, 2022 - 2028, USD Million
TABLE 44 Japan Epigenetics Market by Product, 2018 - 2021, USD Million
TABLE 45 Japan Epigenetics Market by Product, 2022 - 2028, USD Million
TABLE 46 Japan Epigenetics Market by End User, 2018 - 2021, USD Million
TABLE 47 Japan Epigenetics Market by End User, 2022 - 2028, USD Million
TABLE 48 India Epigenetics Market, 2018 - 2021, USD Million
TABLE 49 India Epigenetics Market, 2022 - 2028, USD Million
TABLE 50 India Epigenetics Market by Application, 2018 - 2021, USD Million
TABLE 51 India Epigenetics Market by Application, 2022 - 2028, USD Million
TABLE 52 India Epigenetics Market by Product, 2018 - 2021, USD Million
TABLE 53 India Epigenetics Market by Product, 2022 - 2028, USD Million
TABLE 54 India Epigenetics Market by End User, 2018 - 2021, USD Million
TABLE 55 India Epigenetics Market by End User, 2022 - 2028, USD Million
TABLE 56 South Korea Epigenetics Market, 2018 - 2021, USD Million
TABLE 57 South Korea Epigenetics Market, 2022 - 2028, USD Million
TABLE 58 South Korea Epigenetics Market by Application, 2018 - 2021, USD Million
TABLE 59 South Korea Epigenetics Market by Application, 2022 - 2028, USD Million
TABLE 60 South Korea Epigenetics Market by Product, 2018 - 2021, USD Million
TABLE 61 South Korea Epigenetics Market by Product, 2022 - 2028, USD Million
TABLE 62 South Korea Epigenetics Market by End User, 2018 - 2021, USD Million
TABLE 63 South Korea Epigenetics Market by End User, 2022 - 2028, USD Million
TABLE 64 Singapore Epigenetics Market, 2018 - 2021, USD Million
TABLE 65 Singapore Epigenetics Market, 2022 - 2028, USD Million
TABLE 66 Singapore Epigenetics Market by Application, 2018 - 2021, USD Million
TABLE 67 Singapore Epigenetics Market by Application, 2022 - 2028, USD Million
TABLE 68 Singapore Epigenetics Market by Product, 2018 - 2021, USD Million
TABLE 69 Singapore Epigenetics Market by Product, 2022 - 2028, USD Million
TABLE 70 Singapore Epigenetics Market by End User, 2018 - 2021, USD Million
TABLE 71 Singapore Epigenetics Market by End User, 2022 - 2028, USD Million
TABLE 72 Malaysia Epigenetics Market, 2018 - 2021, USD Million
TABLE 73 Malaysia Epigenetics Market, 2022 - 2028, USD Million
TABLE 74 Malaysia Epigenetics Market by Application, 2018 - 2021, USD Million
TABLE 75 Malaysia Epigenetics Market by Application, 2022 - 2028, USD Million
TABLE 76 Malaysia Epigenetics Market by Product, 2018 - 2021, USD Million
TABLE 77 Malaysia Epigenetics Market by Product, 2022 - 2028, USD Million
TABLE 78 Malaysia Epigenetics Market by End User, 2018 - 2021, USD Million
TABLE 79 Malaysia Epigenetics Market by End User, 2022 - 2028, USD Million
TABLE 80 Rest of Asia Pacific Epigenetics Market, 2018 - 2021, USD Million
TABLE 81 Rest of Asia Pacific Epigenetics Market, 2022 - 2028, USD Million
TABLE 82 Rest of Asia Pacific Epigenetics Market by Application, 2018 - 2021, USD Million
TABLE 83 Rest of Asia Pacific Epigenetics Market by Application, 2022 - 2028, USD Million
TABLE 84 Rest of Asia Pacific Epigenetics Market by Product, 2018 - 2021, USD Million
TABLE 85 Rest of Asia Pacific Epigenetics Market by Product, 2022 - 2028, USD Million
TABLE 86 Rest of Asia Pacific Epigenetics Market by End User, 2018 - 2021, USD Million
TABLE 87 Rest of Asia Pacific Epigenetics Market by End User, 2022 - 2028, USD Million
TABLE 88 key information – Abcam plc
TABLE 89 key Information – Agilent Technologies, Inc.
TABLE 90 Key information – Hologic, Inc.
TABLE 91 key information – Illumina, Inc.
TABLE 92 key Information – Merck GrouP
TABLE 93 key Information – PerkinElmer, Inc.
TABLE 94 Key Information – Qiagen N.V.
TABLE 95 Key Information – Thermo Fisher Scientific, Inc.
TABLE 96 Key Information – Zymo Research
TABLE 97 Key Information – Active Motif, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2018, Apr – 2021, Dec) Leading Players
FIG 5 Recent strategies and developments: PerkinElmer, Inc.
FIG 6 Recent strategies and developments: Active Motif, Inc.